©The Author(s) 2025.
World J Clin Oncol. Nov 24, 2025; 16(11): 111627
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.111627
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.111627
Figure 9 The development of a nomogram.
A: Receiver operating characteristic curve analysis revealed tumor types with area under the curve values > 0.6, based on the combined The Cancer Genome Atlas and Genotype-Tissue Expression databases; B: Risk factors of gender and ectonucleoside triphosphate diphosphohydrolase 6 expression were used to construct a nomogram in thyroid carcinoma; C and D: The calibration curves of the training and testing sets; E and F: The receiver operating characteristic analysis of the training and testing sets; G and H: The decision-curve analysis results of the training and testing sets. bP < 0.01, cP < 0.001. ENTPD6: Ectonucleoside triphosphate diphosphohydrolase 6; AUC: Area under the curve; CI: Confidence interval; ROC: Receiver operating characteristic.
- Citation: Wang G, Liu T, Zhang JX, Li YR, Zhu WJ, Wang JL, Dong WW, Zhang YY, Li YM, Yang LX, He LX, He WT. Systematic pan-cancer analysis reveals the prognostic and immunological roles of ectonucleoside triphosphate diphosphohydrolase 6. World J Clin Oncol 2025; 16(11): 111627
- URL: https://www.wjgnet.com/2218-4333/full/v16/i11/111627.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i11.111627